| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0503002A1 Antisense oligonucleotide inhibition of papillomavirus |
| 09/16/1992 | EP0502962A1 Hirudine polyalkylene glycol conjugates. |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0502897A1 Endothelial-derived il-8 |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0502874A1 Novel peptides derived from neuropeptide y |
| 09/16/1992 | EP0470128A4 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 09/16/1992 | EP0267224B1 Process for the production of a polypeptide |
| 09/16/1992 | EP0187814B1 Diagnostic assay for inhibitor or tissue-type and urokinase-type plasminogen activators |
| 09/16/1992 | CA2105965A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2082929A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | CA2063005A1 Amylin and calcitonin gene-related peptide use and antagonists thereof |
| 09/16/1992 | CA2062460A1 A method of stabilizing recombinant hepatitis b virus surface proteins from recombinant host cells |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016559A1 The trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1992 | WO1992016228A1 TGF-β1/β2: A NOVEL CHIMERIC TRANSFORMING GROWTH FACTOR-BETA |
| 09/15/1992 | US5147856 Administering cyclic peptide prior to, during, and after surgery |
| 09/15/1992 | US5147855 Modified vasoactive intestinal peptide |
| 09/15/1992 | US5147854 Tgf-b compositions and method |
| 09/15/1992 | US5147853 Infection protectant |
| 09/15/1992 | US5147798 Monophenotypic xenograft of megakaryocytic lineage and origin |
| 09/15/1992 | US5147797 Cell culture substrate surface coated with polypeptide which binds heparin and promotes cellular adhesion and neurite outgrowth |
| 09/15/1992 | US5147789 For production of polypeptide analog of an animal growth hormone |
| 09/15/1992 | US5147788 Baculovirus vectors and methods of use |
| 09/15/1992 | US5147782 Protease inhibitor, buffer, chelate compound |
| 09/15/1992 | US5147640 Strains of bacillus thuringiensis insecticidal compositions containing the same |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA2105877A1 Tgf-.beta.1/.beta.2: novel chimeric transforming growth factor-beta |
| 09/15/1992 | CA1307623C Method for synthesizing a peptide containing a non-peptide bond |
| 09/15/1992 | CA1307484C Method for culturing recombinant cells |
| 09/15/1992 | CA1307483C Process for producing protein a and composition thereof |
| 09/15/1992 | CA1307482C Vectors and expression sequences for production of polypeptides |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | WO1992015321A1 Endothelin antagonists |
| 09/09/1992 | EP0502730A1 Nematode control with proteinase inhibitors |
| 09/09/1992 | EP0502719A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502696A1 Diapause hormone of silkworm Bomby x mori |
| 09/09/1992 | EP0502637A2 Vector |
| 09/09/1992 | EP0502607A1 Thymopoietin |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/09/1992 | EP0502589A2 Kit for use in amplifying and detecting nucleic acid sequences |
| 09/09/1992 | EP0502588A2 Process for amplifying nucleic acid sequences |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502536A1 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/09/1992 | EP0502474A2 Curculin B and DNA encoding same, and process for production thereof |
| 09/09/1992 | EP0502236A1 Gene coded for a polypeptide which enhances virus infection of host insects |
| 09/09/1992 | EP0502179A1 Enhanced expression of viral proteins in drosophila cells |
| 09/09/1992 | EP0502171A1 Composition for inducing granulocyte production or b cell production in peripheral blood |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502146A1 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEIN gE |
| 09/09/1992 | EP0502131A1 Production of multimeric glycoproteins through chemical coupling |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502113A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
| 09/09/1992 | EP0502105A1 Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0502050A1 A protein purification method. |
| 09/09/1992 | EP0473716A4 Dominant negative members of the steroid/thyroid superfamily of receptors |
| 09/09/1992 | EP0457898A4 Proteinase inhibitory agents and methods for their use |
| 09/09/1992 | EP0348508B1 Process for separating and purifying lactoferrin from milk using sulfate compound |
| 09/09/1992 | EP0274532B1 Wound-healing drug and cosmetics |
| 09/09/1992 | EP0180595B1 Method of inhibiting and inducing human platelet aggregation |
| 09/09/1992 | CN1064313A Realignment protein of human digestive enzyme and process for their preparation |
| 09/09/1992 | CN1064217A Pneumococcal polysaccharide conjugate vaccine |
| 09/09/1992 | CA2104860A1 Endothelin antagonists |
| 09/08/1992 | US5145962 Human pro relaxin polypeptides |
| 09/08/1992 | US5145951 Protected ologopeptides; treating aids |
| 09/08/1992 | US5145872 Enzyme inhibitors, analgesics |
| 09/08/1992 | US5145837 Administering somatostatin derivative |
| 09/08/1992 | US5145782 DNA expression vector suitable for direct expression of a foreign gene |
| 09/08/1992 | US5145775 Polyhedrin gene and genetic engineering thereof |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA1307374C Peptides containing an aliphatic-aromatic ketone side chain |
| 09/08/1992 | CA1307373C Process for the isolation and preparation of a pasteurized alpha_-antiplasmin product |
| 09/08/1992 | CA1307289C2 Peptidylaminodiols |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/07/1992 | WO1992015681A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 09/07/1992 | CA2105572A1 Human galanin, cdna clones encoding human galanin and a method of producing human galanin |
| 09/06/1992 | WO1992015610A1 Hirudin analogue or salt thereof, production thereof, and anticoagulant containing the same as active ingredient |
| 09/06/1992 | CA2081305A1 Hirudin variants or their salts, method for their production and anticoagulants having said compounds as active ingredients |
| 09/05/1992 | CA2062262A1 Polypeptide |
| 09/05/1992 | CA2062174A1 Curculin b and dna encoding same, and process for production thereof |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/05/1992 | CA2061861A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992015015A1 Methods for detecting galanin antagonists |